Caprock Group LLC acquired a brand new place in Fresenius Medical Care AG (NYSE:FMS – Free Report) throughout the 2nd quarter, based on the corporate in its most up-to-date Kind 13F submitting with the Securities & Trade Fee. The fund acquired 10,879 shares of the corporate’s inventory, valued at roughly $208,000.
Different institutional buyers have additionally just lately purchased and bought shares of the corporate. GAMMA Investing LLC boosted its holdings in shares of Fresenius Medical Care by 21.8% within the 1st quarter. GAMMA Investing LLC now owns 4,230 shares of the corporate’s inventory value $82,000 after shopping for an extra 758 shares over the last quarter. QRG Capital Administration Inc. boosted its stake in Fresenius Medical Care by 19.5% within the first quarter. QRG Capital Administration Inc. now owns 54,363 shares of the corporate’s inventory valued at $1,048,000 after buying an extra 8,870 shares over the last quarter. SG Americas Securities LLC grew its place in shares of Fresenius Medical Care by 50.0% throughout the 1st quarter. SG Americas Securities LLC now owns 15,228 shares of the corporate’s inventory valued at $294,000 after buying an extra 5,078 shares throughout the interval. Legacy Wealth Asset Administration LLC purchased a brand new place in shares of Fresenius Medical Care throughout the 1st quarter valued at roughly $584,000. Lastly, Assetmark Inc. elevated its stake in shares of Fresenius Medical Care by 169.9% throughout the 4th quarter. Assetmark Inc. now owns 4,178 shares of the corporate’s inventory value $87,000 after buying an extra 2,630 shares over the last quarter. Institutional buyers personal 8.25% of the corporate’s inventory.
Fresenius Medical Care Inventory Efficiency
Shares of FMS inventory opened at $21.09 on Friday. The agency’s 50 day transferring common is $19.45 and its 200 day transferring common is $19.88. The inventory has a market capitalization of $12.38 billion, a P/E ratio of 23.70, a PEG ratio of 1.09 and a beta of 0.90. Fresenius Medical Care AG has a 12 month low of $16.37 and a 12 month excessive of $23.29. The corporate has a present ratio of 1.46, a fast ratio of 1.09 and a debt-to-equity ratio of 0.45.
Fresenius Medical Care (NYSE:FMS – Get Free Report) final posted its earnings outcomes on Tuesday, July thirtieth. The corporate reported $0.38 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.38. The agency had income of $5.13 billion for the quarter, in comparison with the consensus estimate of $5.28 billion. Fresenius Medical Care had a return on fairness of 5.48% and a web margin of two.72%. On common, sell-side analysts anticipate that Fresenius Medical Care AG will submit 1.51 earnings per share for the present yr.
Wall Road Analysts Forecast Development
A number of equities analysts just lately commented on FMS shares. StockNews.com initiated protection on Fresenius Medical Care in a analysis be aware on Saturday. They issued a “strong-buy” ranking on the inventory. Truist Monetary reduce their worth goal on Fresenius Medical Care from $24.00 to $22.00 and set a “maintain” ranking for the corporate in a analysis be aware on Wednesday, July thirty first. One funding analyst has rated the inventory with a promote ranking, two have assigned a maintain ranking, one has assigned a purchase ranking and one has given a robust purchase ranking to the corporate’s inventory. Based on knowledge from MarketBeat, the inventory has a consensus ranking of “Maintain” and a consensus worth goal of $22.00.
Learn Our Newest Inventory Report on FMS
Fresenius Medical Care Firm Profile
Fresenius Medical Care AG gives dialysis and associated providers for people with renal ailments in Germany, North America, and internationally. The corporate provides dialysis remedy and associated laboratory and diagnostic providers by means of a community of outpatient dialysis clinics; supplies, coaching, and affected person assist providers comprising scientific monitoring, follow-up help, and arranging for supply of the provides to the affected person’s residence; and dialysis providers below contract to hospitals in america for the hospitalized end-stage renal illness (ESRD) sufferers and for sufferers affected by acute kidney failure.
Featured Articles
Obtain Information & Scores for Fresenius Medical Care Day by day – Enter your e-mail tackle beneath to obtain a concise each day abstract of the most recent information and analysts’ scores for Fresenius Medical Care and associated firms with MarketBeat.com’s FREE each day e-mail e-newsletter.
